🇺🇸 FDA
Patent

US 9358249

Use of Pateamine A for the treatment of age-related muscle wasting

granted A61KA61K31/7105A61P

Quick answer

US patent 9358249 (Use of Pateamine A for the treatment of age-related muscle wasting) held by The Regents of the University of California expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/7105, A61P, A61P3/00, A61P39/06